Publications

Export 7 results:
Author [ Title(Desc)] Type Year
Filters: Author is Pietrancosta, Nicolas  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Orrico-Sanchez A, Chausset-Boissarie L, de Sousa RAlves, Coutens B, Amin SRezai, Vialou V, Louis F, Hessani A, Dansette PM, Zornoza T et al..  2019.  Antidepressant efficacy of a selective organic cation transporter blocker in a mouse model of depression.. Mol Psychiatry.
C
Ramet L, Zimmermann J, Bersot T, Poirel O, De Gois S, Silm K, Sakae DYae, Mansouri-Guilani N, Bourque M-J, Trudeau L-É et al..  2017.  Characterization of a Human Point Mutation of VGLUT3 (p.A211V) in the Rodent Brain Suggests a Nonuniform Distribution of the Transporter in Synaptic Vesicles.. J Neurosci. 37(15):4181-4199.
De Gois S, Slama P, Pietrancosta N, Erdozain AM, Louis F, Bouvrais-Veret C, Daviet L, Giros B.  2015.  Ctr9, a Protein in the Transcription Complex Paf1, Regulates Dopamine Transporter Activity at the Plasma Membrane.. J Biol Chem. 290(29):17848-62.
D
Favre-Besse F-C, Poirel O, Bersot T, Kim-Grellier E, Daumas S, Mestikawy SEl, Acher FC, Pietrancosta N.  2014.  Design, synthesis and biological evaluation of small-azo-dyes as potent Vesicular Glutamate Transporters inhibitors.. Eur J Med Chem. 78:236-47.
L
Poirel O, Mamer LE, Herman MA, Arnulf-Kempcke M, Kervern M, Potier B, Miot S, Wang J, Favre-Besse F-C, Brabet I et al..  2019.  LSP5-2157 a new inhibitor of vesicular glutamate transporters.. Neuropharmacology. 164:107902.
M
Pietrancosta N, Djibo M, Daumas S, Mestikawy SEl, Erickson JD.  2020.  Molecular, Structural, Functional, and Pharmacological Sites for Vesicular Glutamate Transporter Regulation.. Mol Neurobiol. 57(7):3118-3142.
S
Erdozain AM, De Gois S, Bernard V, Gorgievski V, Pietrancosta N, Dumas S, Macedo CE, Vanhoutte P, Ortega JE, J Meana J et al..  2017.  Structural and Functional Characterization of the Interaction of Snapin with the Dopamine Transporter: Differential Modulation of Psychostimulant Actions.. Neuropsychopharmacology.